Monday, May 8 will be the last day to submit your comments to the USPSTF draft recommendation on PSA testing. We encourage everyone in the prostate cancer community to review the draft and to make their opinions known regarding the proposed content.  

On April 11, the U.S. Preventive Services Task Force (USPSTF) released their latest draft recommendation statement for prostate-specific antigen (PSA)–based screening for prostate cancer and issued a “C” rating for men who are between 55 and 69 years of age. This is an improvement over the previous “D” recommendation issued by the task force in 2012, which advised against all PSA screening. The new statement also recognizes that the decision on whether or not to have a PSA test should be specific to each individual based on an informed decision following a conversation between a man and his physician. Us TOO issued a press release in response .

The draft recommendation statement and draft evidence reviews are available for public comment through May 8, 2017. The Task Force has developed answers to frequently asked questions, a fact sheet, and an infographic to help clarify the draft recommendations. We encourage you to access this information, review the draft recommendation statement and submit comments at: .